Published at Aug 30, 2022 7:52 PM by seekingalpha.com mixed mixed Voxtur Analytics Corp. (VXTRF) Q2 2022 Earnings Call Transcript Voxtur Analytics (OTCQB:VXTRF) Q4 2022 Earnings Conference Call August 30, 2022 8:00 a.m. YIFMCKLFMCCIFMCCBMON.MXBMOVXTRFVXTR.VILATFBLUWWBLUWUBLUW Read more →
Published at Apr 10, 2022 11:24 PM by etfdailynews.com positive positive Analysts Expect Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Will Post Earnings of -$0.86 Per Share Read Analysts Expect Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Will Post Earnings of -$0.86 Per Share at ETF Daily News UBSN.MXUBSGEE.SWUBSGE.SWUBSG34.SAUBSG.SWUBSCRXTBLUWWBLUWUBLUW Read more →
Published at Apr 10, 2022 2:34 PM by etfdailynews.com positive positive Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Receives Consensus Recommendation of “Buy” from Brokerages Read Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Receives Consensus Recommendation of “Buy” from Brokerages at ETF Daily News UBSN.MXUBSGEE.SWUBSGE.SWUBSG34.SAUBSG.SWUBSCRXTBLUWWBLUWUBLUW Read more →
Published at Apr 8, 2022 5:50 PM by etfdailynews.com positive positive Zacks: Analysts Anticipate Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Will Post Quarterly Sales of $5.30 Million Read Zacks: Analysts Anticipate Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Will Post Quarterly Sales of $5.30 Million at ETF Daily News CRXTBLUWWBLUWUBLUW Read more →
Published at Apr 7, 2022 9:22 AM by etfdailynews.com positive positive Clarus Therapeutics (NASDAQ:CRXT) Lifted to “Buy” at Zacks Investment Research Read Clarus Therapeutics (NASDAQ:CRXT) Lifted to “Buy” at Zacks Investment Research at ETF Daily News BLUWWBLUWUBLUW Read more →
Published at Apr 4, 2022 10:14 AM by etfdailynews.com positive positive Clarus Therapeutics (NASDAQ:CRXT) Price Target Cut to $8.00 by Analysts at Needham & Company LLC Read Clarus Therapeutics (NASDAQ:CRXT) Price Target Cut to $8.00 by Analysts at Needham & Company LLC at ETF Daily News BLUWWBLUWUBLUW Read more →
Published at Apr 1, 2022 1:34 PM by etfdailynews.com positive positive Clarus Therapeutics (NASDAQ:CRXT) Issues Earnings Results, Beats Expectations By $0.49 EPS Read Clarus Therapeutics (NASDAQ:CRXT) Issues Earnings Results, Beats Expectations By $0.49 EPS at ETF Daily News UBSN.MXUBSGEE.SWUBSGE.SWUBSG34.SAUBSG.SWUBSBLUWWBLUWUBLUW Read more →
Published at Apr 1, 2022 1:30 AM by etfdailynews.com positive positive Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Sees Large Growth in Short Interest Read Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Sees Large Growth in Short Interest at ETF Daily News UBSN.MXUBSGEE.SWUBSGE.SWUBSG34.SAUBSG.SWUBSCRXTBLUWWBLUWUBLUW Read more →
Published at Mar 20, 2022 6:28 PM by etfdailynews.com positive positive Brokerages Anticipate Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Will Post Quarterly Sales of $4.80 Million Read Brokerages Anticipate Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Will Post Quarterly Sales of $4.80 Million at ETF Daily News CRXTCOWNLCOWNCLARBLUWWBLUWUBLUW Read more →
Published at Mar 19, 2022 10:06 AM by etfdailynews.com positive positive Clarus Therapeutics (NASDAQ:CRXT) Lifted to Hold at Zacks Investment Research Read Clarus Therapeutics (NASDAQ:CRXT) Lifted to Hold at Zacks Investment Research at ETF Daily News BLUWWBLUWUBLUW Read more →
Published at Aug 7, 2021 8:00 PM by markets.businessinsider.com mixed mixed August SPAC Merger Vote Calendar: A Look At Upcoming Votes And Stocks To Watch The months of June and July were among the busiest for SPAC merger votes so far in 2021. August is now filling up with several deal votes hap... SNPRSCPERMG-UNNSH-WTNSH-UNNSHNGACKSMTCFFACFACWCFACUCFACBLUWWBLUWUBLUWBCTGAJAX-UNAJAXVACQSVSVWSVSVUSVSRACWSRACUSRACSAIIWSAIIUSAIIRTP-UNRTPNBA-WTNBA-UNNBAMUDSWMUDSUMUDSLIVKWLIVKULIVKGWACWGWACUGWACGRNVWGRNVUGRNVRGRNVCENHWCENHUCENH Read more →